Analytical Data
-
基因名
ADAD1
- Application
-
别名
ADAD1; TENR; Adenosine deaminase domain-containing Protein 1; Testis nuclear RNA-binding Protein
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96M93
-
表达区间
1-565aa
-
氨基酸序列
MASNNHWFQSSQVPSFAQMLKKNLPVQPATKTITTPTGWSSESYGLSKMASKVTQVTGNFPEPLLSKNLSSISNPVLPPKKIPKEFIMKYKRGEINPVSALHQFAQMQRVQLDLKETVTTGNVMGPYFAFCAVVDGIQYKTGLGQNKKESRSNAAKLALDELLQLDEPEPRILETSGPPPFPAEPVVLSELAYVSKVHYEGRHIQYAKISQIVKERFNQLISNRSEYLKYSSSLAAFIIERAGQHEVVAIGTGEYNYSQDIKPDGRVLHDTHAVVTARRSLLSKNPAMMEKSIFCTEPTSNLLTLKQNINICLYMNQLPKGSAQIKSQLRLNPHSISAFEANEELCLHVAVEGKIYLTVYCPKDGVNRISSMSSSDKLTRWEVLGVQGALLSHFIQPVYISSILIGDGNCSDTRGLEIAIKQRVDDALTSKLPMFYLVNRPHISLVPSAYPLQMNLEYKFLSLNWAQGDVSLEIVDGLSGKITESSPFKSGMSMASRLCKAAMLSRFNLLAKEAKKELLEAGTYHAAKCMSASYQEAKCKLKSYLQQHGYGSWIVKSPCIEQFNM
-
分子量
89.2 KDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ADAD1, or adenosine deaminase acting on RNA 1, is a key RNA-binding protein involved in post-transcriptional gene regulation. Research into ADAD1 has gained momentum due to its potential implications in various biological processes and diseases, including cancer and neurodegenerative disorders. The protein is known to play critical roles in RNA editing and splicing, influencing the stability and translation of target mRNAs. Dysregulation of ADAD1 expression and function has been linked to altered cellular responses, contributing to tumorigenesis and other pathological conditions. Consequently, the study of ADAD1 recombination proteins has emerged as a promising avenue for understanding its precise molecular mechanisms and therapeutic potential. Researchers are exploring the engineering of ADAD1 to enhance its stability, specificity, and efficacy in a range of applications, from basic research to therapeutic interventions. By elucidating the roles of ADAD1 and its recombinant variants, scientists aim to develop strategies for targeted therapies that could address the underlying molecular dysregulation in various diseases, paving the way for innovative treatments and improved patient outcomes.












